Article 1
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) 2015/1885 of 20 October 2015 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-D, acibenzolar-s-methyl, amitrole, bentazone, cyhalofop butyl, diquat, esfenvalerate, famoxadone, flumioxazine, DPX KE 459 (flupyrsulfuron-methyl), glyphosate, iprovalicarb, isoproturon, lambda-cyhalothrin, metalaxyl-M, metsulfuron methyl, picolinafen, prosulfuron, pymetrozine, pyraflufen-ethyl, thiabendazole, thifensulfuron-methyl and triasulfuron (Text with EEA relevance)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 7, Metsulfuron methyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (2) in the sixth column, expiration of approval, of row 9, Triasulfuron, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (3) in the sixth column, expiration of approval, of row 10, Esfenvalerate, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (4) in the sixth column, expiration of approval, of row 11, Bentazone, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (5) in the sixth column, expiration of approval, of row 12, Lambda-cyhalothrin, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (6) in the sixth column, expiration of approval, of row 14, Amitrole, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (7) in the sixth column, expiration of approval, of row 15, Diquat, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (8) in the sixth column, expiration of approval, of row 17, Thiabendazole, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (9) in the sixth column, expiration of approval, of row 19, DPX KE 459 (flupyrsulfuron-methyl), the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (10) in the sixth column, expiration of approval, of row 20, Acibenzolar-s-methyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (11) in the sixth column, expiration of approval, of row 23, Pymetrozine, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (12) in the sixth column, expiration of approval, of row 24, Pyraflufen-ethyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (13) in the sixth column, expiration of approval, of row 25, Glyphosate, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (14) in the sixth column, expiration of approval, of row 26, Thifensulfuron-methyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (15) in the sixth column, expiration of approval, of row 27, 2,4-D, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (16) in the sixth column, expiration of approval, of row 28, Isoproturon, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (17) in the sixth column, expiration of approval, of row 30, Iprovalicarb, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (18) in the sixth column, expiration of approval, of row 31, Prosulfuron, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (19) in the sixth column, expiration of approval, of row 34, Cyhalofop butyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (20) in the sixth column, expiration of approval, of row 35, Famoxadone, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (21) in the sixth column, expiration of approval, of row 37, Metalaxyl-M, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (22) in the sixth column, expiration of approval, of row 38, Picolinafen, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’; (23) in the sixth column, expiration of approval, of row 39, Flumioxazine, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.